Androgen replacement therapy in women

Current Opinion in Investigational Drugs

Volumn 6, Issue 10, 2005, Pages 1028-1036

  Arlt, Wiebke ^a  

^a Institute of Biomedical Research   (United Kingdom)

Author keywords

Androgen replacement; DHEA; Female androgen deficiency; Randomized controlled trials; Testosterone; Women

Indexed keywords

ANDROGEN; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; CYPROTERONE ACETATE; DROSPIRENONE; ESTRADIOL; ESTROGEN; GESTAGEN; METHYLTESTOSTERONE; OXANDROLONE; PRASTERONE; TESTOSTERONE; TESTOSTERONE DERIVATIVE; TESTOSTERONE ETHANATE; TESTOSTERONE UNDECANOATE; UNCLASSIFIED DRUG;

ADDISON DISEASE; ADRENAL FUNCTION; ALOPECIA; ANDROGEN DEFICIENCY; ANDROGEN METABOLISM; ANDROGEN SYNTHESIS; ANDROGEN THERAPY; CLINICAL TRIAL; DRUG APPROVAL; DRUG HALF LIFE; FEMALE; HAIR DISEASE; HIRSUTISM; HUMAN; LIBIDO; MENOPAUSE; MOOD; OVARIECTOMY; OVARY FUNCTION; REVIEW; SKIN MANIFESTATION; SWEAT GLAND DISEASE;

ADRENAL INSUFFICIENCY; ANDROGENS; ANIMALS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 27544443952     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM et al: Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc (2002) 288(3):321-333.
2. Allolio B, Arlt W: DHEA treatment: Myth or reality? Trends Endocrinol Metab (2002) 13(7):288-294.
3. Hammer F, Subtil S, Lux P, Maser-Gluth C, Stewart PM, Allolio B, Arlt W: No evidence for hepatic conversion of dehydroepiandrosterone (DHEA) sulfate to DHEA: In vivo and in vitro studies. J Clin Endocrinol Metab (2005) 90(6):3600-3605.
4. Haning RV Jr, Austin CW, Carlson IH, Kuzma DL, Zweibel WJ: Role of dehydroepiandrosterone sulfate as a prehormone for ovarian steroidogenesis. Obstet Gynecol (1985) 65(2):199-205.
5. Arlt W, Justl HG, Callies F, Reincke M, Hubler D, Oettel M, Ernst M, Schulte HM, Allolio B: Oral dehydroepiandrosterone for adrenal androgen replacement: Pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J Clin Endocrinol Metab (1998) 83(6):1928-1934.
6. Orentreich N, Brind JL, Rizer RL, Vogelman JH: Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab (1984) 59(3):551-555.
7. Orentreich N, Brind JL, Vogelman JH, Andres R, Baldwin H: Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab (1992) 75(4):1002-1004.
8. Arlt W: Dehydroepiandrosterone and ageing. Best Pract Res Clin Endocrinol Metab (2004) 18(3):363-380.
9. Couzinet B, Meduri G, Lecce MG, Young J, Brailly S, Loosfelt H, Milgrom E, Schaison G: The postmenopausal ovary is not a major androgen-producing gland. J Clin Endocrinol Metab (2001) 86(10):5060-5066.
10. Burger HG: Androgen production in women. Fertil Steril (2002) 77(Suppl 4):S3-S5.
11. Miller KK, Sesmilo G, Schiller A, Schoenfeld D, Burton S, Klibanski A: Androgen deficiency in women with hypopituitarism. J Clin Endocrinol Metab (2001) 86(2):561-567.
12. Davison SL, Bell R, Donath S, Montalto JG, Davis SR: Androgen levels in adult females: Changes with age, menopause and oophorectomy. J Clin Endocrinol Metab (2005) 90(7):3847-3853.
13. Laughlin GA, Barrett-Connor E, Kritz-Silverstein D, von Muhlen D: Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: The Rancho Bernardo Study. J Clin Endocrinol Metab (2000) 85(2):645-651.
14. Bachmann G, Bancroft J, Braunstein G, Burger H, Davis S, Dennerstein L, Goldstein I, Guay A, Leiblum S, Lobo R, Notelovitz M et al: Female androgen insufficiency: The Princeton consensus statement on definition, classification, and assessment. Fertil Steril (2002) 77(4):660-665.
15. Davis SR, Davison SL, Donath S, Bell RJ: Circulating androgen levels and sell-reported sexual function in women. J Am Med Assoc (2005) 294(1):91-96.
16. Gravholt CH, Svenstrup B, Bennett P, Sandahl Christiansen J: Reduced androgen levels in adult turner syndrome: Influence of female sex steroids and growth hormone status. Clin Endocrinol (1999) 50(6):791-800.
17. Bancroft J, Cawood EH: Androgens and the menopause; a study of 40-60-year-old women. Clin Endocrinol (1996) 45(5):577-587.
18. Myers LS, Dixen J, Morrissette D, Carmichael M, Davidson JM: Effects of estrogen, androgen, and progestin on sexual psychophysiology and behavior in postmenopausal women. J Clin Endocrinol Metab (1990) 70(4):1124-1131.
19. Buckler HM, Robertson WR, Wu FC: Which androgen replacement therapy for women? J Clin Endocrinol Metab (1998) 83(11):3920-3924.
20. Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, Burki RE, Ginsburg ES, Rosen RC, Leiblum SR, Caramelli KE, Mazer NA: Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med (2000) 343(10):682-688.
21. Ross JL, Roeltgen D, Stefanatos GA, Feuillan P, Kushner H, Bondy C, Cutler GB Jr: Androgen-responsive aspects of cognition in girls with Turner syndrome. J Clin Endocrinol Metab (2003) 88(1):292-296.
22. Kemppainen JA, Langley E, Wong CI, Bobseine K, Kelce WR, Wilson EM: Distinguishing androgen receptor agonists and antagonists: Distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone. Mol Endocrinol (1999) 13(3):440-454.
23. Arlt W: Dehydroepiandrosterone replacement therapy. Samin Reprod Med (2004) 22(4):379-388.
24. Young J, Couzinet B, Nahoul K, Brailly S, Chanson P, Baulieu EE, Schaison G: Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans. J Clin Endocrinol Metab (1997) 82(8):2578-2585.
25. Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M, Huebler D, Oettel M, Ernst M, Schulte HM, Allolio B: Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med (1999) 341(14):1013-1020.
26. Parasrampuria J, Schwartz K, Petesch R: Quality control of dehydroepiandrosterone dietary supplement products. J Am Med Assoc (1998) 280(18):1565.
27. Montgomery JC, Appleby L, Brincat M, Versi E, Tapp A, Fenwick PB, Studd JW: Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet (1987) 1(8528):297-299.
28. Barrett-Connor E, Young R, Notelovitz M, Sullivan J, Wiita B, Yang HM, Nolan J: A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles. J Reprod Med (1999) 44(12):1012-1020.
29. Davis SR, McCloud P, Strauss BJ, Burger H: Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturilas (1995) 21(3):227-236.
30. Dobs AS, Nguyen T, Pace C, Roberts CP: Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women. J Clin Endocrinol Metab (2002) 87(4):1509-1516.
31. Lovejoy JC, Bray GA, Bourgeois MO, Macchiavelli R, Rood JC, Greeson C, Partington C: Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women - a clinical research center study. J Clin Endocrinol Metab (1996) 81(6):2198-2203.
32. Buckler HM, McElhone K, Durrington PN, Mackness MI, Ludlam CA, Wu FC: The effects of low-dose testosterone treatment on lipid metabolism, clotting factors and ultrasonographic ovarian morphology in women. Clin Endocrinol (1998) 49(2):173-178.
33. Sherwin BB, Gelfand MM, Brender W: Androgen enhances sexual motivation in females: A prospective, crossover study of sex steroid administration in the surgical menopause. Psychosom Med (1985) 47(4):339-351.
34. Sherwin BB, Gelfand MM: Sex steroids and affect in the surgical menopause: A double-blind, cross-over study. Psychoneuro-endocrinology (1985) 10(3):325-335.
35. Lovas K, Loge JH, Husebye ES: Subjective health status in Norwegian patients with Addison's disease. Clin Endocrinol (2002) 56(5):581-588.
36. Hunt PJ, Gurnell EM, Huppert FA, Richards C, Prevost AT, Wass JA, Herbert J, Chatterjee VK: Improvement In mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J Clin Endocrinol Metab (2000) 85(12):4650-4656.
37. Johannsson G, Burman P, Wiren L, Engstrom BE, Nilsson AG, Ottosson M, Jonsson B, Bengtsson BA, Karlsson FA: Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: A placebo-controlled trial. J Clin Endocrinol Metab (2002) 87(5):2046-2052.
38. Bloch M, Schmidt PJ, Danaceau MA, Adams LF, Rubinow DR: Dehydroepiandrosterone treatment of midlife dysthymia. Biol Psychiatry (1999) 45(12):1533-1541.
39. Schmidt PJ, Daly RC, Bloch M, Smith MJ, Danaceau MA, St Clair LS, Murphy JH, Haq N, Rubinow DR: Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch Gen Psychiatry (2005) 62(2):154-162.
40. Barnhart KT, Freeman E, Grisso JA, Rader DJ, Sammel M, Kapoor S, Nestler JE: The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. J Clin Endocrinol Metab (1999) 84(11):3896-3902.
41. Baulieu EE, Thomas G, Legrain S, Lahlou N, Roger M, Debuire B, Faucounau V, Girard L, Hervy MP, Latour F, Leaud MC et al: Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: Contribution of the DHEAge study to a sociobiomedical issue. Proc Natl Acad Sci USA (2000) 97(8):4279-4284.
42. Dhatariya K, Bigelow ML, Nair KS: Effect of dehydroepiandrosterone replacement on insulin sensitivity and lipids in hypoadrenal women. Diabetes (2005) 54(3):765-769.
43. Villareal DT, Holloszy JO: Effect of DHEA on abdominal fat and insulin action in elderly women and men: A randomized controlled trial. J Am Med Assoc (2004) 292(18):2243-2248.
44. Watts NB, Notelovitz M, Timmons MC, Addison WA, Wiita B, Downey LJ: Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause. Obstet Gynecol (1995) 85(4):529-537.
45. Raisz LG, Wiita B, Artis A, Bowen A, Schwartz S, Trahiotis M, Shoukri K, Smith J: Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Clin Endocrinol Metab (1996) 81(1):37-43.
46. Miller K, Corcoran C, Armstrong C, Caramelli K, Anderson E, Cotton D, Basgoz N, Hirschhom L, Tuomala R, Schoenfeld D, Daugherty C et al: Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: A pilot study. J Clin Endocrinol Metab (1998) 83(8):2717-2725.
47. Callies F, Fassnacht M, van Vlijmen JC, Koehler I, Huebler D, Seibel MJ, Arlt W, Allolio B: Dehydroepiandrosterone replacement in women with adrenal insufficiency: Effects on body composition, serum leptin, bone turnover, and exercise capacity. J Clin Endocrinol Metab (2001) 86(5):1968-1972.
48. Lovas K, Gebre-Medhin G, Trovik TS, Fougner KJ, Uhlving S, Nedrebo BG, Myking OL, Kampe O, Husebye ES: Replacement of dehydroepiandrosterone in adrenal failure: No benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. J Clin Endochnol Metab (2003) 88(3):1112-1118.
49. Morales AJ, Nolan JJ, Nelson JC, Yen SS: Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab (1994) 78(6):1360-1367.
50. Yen SS, Morales AJ, Khorram O: Replacement of DHEA in aging men and women. Potential remedial effects. Ann NY Acad Sci (1995) 774:128-142.
51. Morales AJ, Haubrich RH, Hwang JY, Asakura H, Yen SS: The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol (1998) 49(4):421-432.
52. Casson PR, Santoro N, Elkind-Hirsch K, Carson SA, Hornsby PJ, Abraham G, Buster JE: Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: A six-month trial. Fertil Steril (1998) 70(1):107-110.
53. Lasco A, Frisina N, Morabito N, Gaudio A, Morini E, Trifiletti A, Basile G, Nicita-Mauro V, Cucinotta D: Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women. Eur J Endocrinol (2001) 145(4):457-461.